Department of Vascular Surgery, Semmelweis University, H-1122, Városmajor u. 68, Budapest, Hungary.
Langenbecks Arch Surg. 2011 Dec;396(8):1221-9. doi: 10.1007/s00423-011-0807-6. Epub 2011 May 21.
We reviewed the perioperative and long-term outcomes after the surgical management of secondary aortoenteric fistulas.
Over a 20-year period (1989-2009), 48 patients (33 men and 15 women; mean age, 64 years) were treated for secondary aortoenteric fistulas (SAEF). Most of the patients presented with symptoms of gastrointestinal bleeding (42 cases), or of serious septicaemia and general septic conditions (19 cases). Twenty-eight patients (58.3%) required an emergency procedure and were admitted with an unstable hemodynamic status. Repairs were accomplished by graft removal and an axillobifemoral bypass (n = 11), in situ reconstruction with a silver-impregnated prosthetic replacement (n = 21), a Dacron graft replacement (n = 7), a cryopreserved homograft replacement (n = 8) or an in situ deep vein replacement (n = 2).
Early perioperative (<30 day) mortality was 45.8%. There was a significant difference in the mortality rates between patients who had an emergency procedure (59.2%) and patients who underwent urgent (38.0%) operations (p < 0.04). The average follow-up period was 48.6 ± 16 months. There were eight late deaths; three of which were related to the SAEF treatment. The cumulative mortality rate was 34% at 3 years. The in situ silver graft replacement group cumulative survival rate was 72% at 3 years. No significant difference was observed in mortality on the complete or partial graft removal. Six late graft failures occurred; four of them resulted in amputation and three of them were associated with a recurrent infection. Freedom from amputation was 76.5% at both 3 and 5 years. Late infections occurred in six patients. Freedom from recurrent infection was 80.8% and 81.4% at 3 years in the whole study group and in the in situ silver graft group, respectively. The infect free rate at 3 years was the same compared the complete or partial graft removal
The long-term outcomes associated with aortoenteric fistula repair might be favourable when silver-impregnated grafts were used as an in situ strategy. The eradication of infection is possible in mid-term follow-up with partial graft replacement, which associated with a lesser operative load.
我们回顾了继发性主动脉肠瘘(secondary aortoenteric fistulas,SAEF)手术治疗的围手术期和长期结果。
在 20 年期间(1989 年至 2009 年),48 名患者(33 名男性和 15 名女性;平均年龄 64 岁)接受了 SAEF 的治疗。大多数患者出现胃肠道出血(42 例)或严重败血症和全身败血症(19 例)的症状。28 例(58.3%)需要紧急手术,且入院时血流动力学不稳定。通过移植物切除和腋股旁路(n=11)、原位用银浸渍假体置换(n=21)、Dacron 移植物置换(n=7)、冷冻同种异体移植置换(n=8)或原位深静脉置换(n=2)完成修复。
早期围手术期(<30 天)死亡率为 45.8%。急诊手术(59.2%)与紧急手术(38.0%)患者的死亡率存在显著差异(p<0.04)。平均随访时间为 48.6±16 个月。有 8 例晚期死亡,其中 3 例与 SAEF 治疗有关。3 年累积死亡率为 34%。原位银制移植物置换组 3 年累积生存率为 72%。完全或部分移植物切除的死亡率无显著差异。6 例晚期移植物失败,其中 4 例导致截肢,3 例与再次感染有关。3 年和 5 年时的免于截肢率分别为 76.5%和 76.5%。6 例患者发生迟发性感染。在整个研究组和原位银制移植物组中,3 年时的无复发性感染率分别为 80.8%和 81.4%。3 年时,感染无复发生存率与完全或部分移植物切除相同。
当使用银浸渍移植物作为原位策略时,主动脉肠瘘修复的长期结果可能是有利的。在中期随访中,通过部分移植物置换可以根除感染,且手术负荷较小。